Metabolomics analysis delineates the therapeutic effects of Yinlan Tiaozhi capsule on triton WR-1339 -induced hyperlipidemia in mice by Guanlin Xiao, Aili Xu, Jieyi Jiang, Zhao Chen, Yangxue Li, Sumei Li, Weitao Chen, Jingnian Zhang, Canchao Jia, Zhihao Zeng, Xiaoli Bi, Xiaoli Bi

Connect to this object online.

Metabolomics and network pharmacology reveal partial insights into the hypolipidemic mechanisms of ferulic acid in a dyslipidemia mouse model by Zhihao Zeng, Guanlin Xiao, Yanchang Liu, Minshan Wu, Xingqin Wei, Canhui Xie, Guangying Wu, Dezheng Jia, Yangxue Li, Sumei Li, Xiaoli Bi, Xiaoli Bi

Connect to this object online.

P-glycoprotein mediated interactions between Chinese materia medica and pharmaceutical drugs by Xi Yang, Yuzhong Peng, Yufei He, Xuejun Huang, Aili Xu, Xiaoli Bi, Ying Xie

Connect to this object online.

Selection and evaluation of quality control markers in propolis based on its hyperlipidemia therapy via regulating PXR/CYP3A4 expression by Zhao Chen, Wenhui Luo, Dongmei Sun, Xiaoli Bi, Xiaohui Zeng, Guanlin Xiao, Aili Xu, Weitao Chen, Jieyi Jiang, Xiyuan Li, Lizhong Cao

Connect to this object online.

The anti-hyperlipidemia effect of Yinlan capsule via regulation of PXR activity by Zhao Chen, Dongmei Li, Xi-Yuan Li, Guanlin Xiao, Xiaoli Bi, Weitao Chen, Zhiqi Shi, Xiaohui Zeng, Dongmei Sun, Li-Zhong Cao

Connect to this object online.